Back to Results

Ping An Biomedical Co Ltd (PASW)

Ping An Biomedical Co., Ltd. is a Hong Kong-based company listed on NASDAQ under the ticker PASW. Through its subsidiaries, it provides supply chain management services for the apparel industry across China, Hong Kong, Cambodia, and Europe. Its activities include market analysis, product design and development support, sourcing of raw materials, production and quality oversight, and logistics coordination. The group also works in the manufacturing and trading of yarns, textiles, and finished garments, alongside warehousing services and real estate property investment. Its customer base includes brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. Founded in 2013, the company was formerly known as Majestic Ideal Holdings Ltd. and adopted its current name in September 2025. It operates as a subsidiary of Action Holdings Limited.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-PASW
$0.13
-15.3% Downside
Fair
—
—
—
Weak
—
—
—
0.0%
—
-9.9x
2.8x
3.7x
18.172 M
19.008 M
7.6%
78.3%
6.8
—
50.1%
Send a message
Valuation • Fair Value

Ping An Biomedical Co Ltd (NASDAQ-PASW) Fair Value by Valuation Model

Compare the primary fair value estimate for Ping An Biomedical Co Ltd (NASDAQ-PASW) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.13

Estimated downside of 15.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.13

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.13

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Ping An Biomedical Co Ltd (NASDAQ-PASW) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Ping An Biomedical Co Ltd (NASDAQ-PASW)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

4.797 M

Current operating scale indicator.

Revenue Forecast

5.046 M

Forward revenue estimate.

EBITDA

-2.064 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Ping An Biomedical Co Ltd (NASDAQ-PASW) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ping An Biomedical Co Ltd (NASDAQ-PASW)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-3.52

No elevated caution signal from this screen.

Altman Z-Score

6.8

Relatively strong balance-sheet zone.

FCF / Net Income

50.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ping An Biomedical Co Ltd (NASDAQ-PASW). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ping An Biomedical Co Ltd (NASDAQ-PASW)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Ping An Biomedical Co Ltd (NASDAQ-PASW), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ping An Biomedical Co Ltd (NASDAQ-PASW) Stock Forecast & Technical Outlook

Review Ping An Biomedical Co Ltd (NASDAQ-PASW) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ping An Biomedical Co Ltd (NASDAQ-PASW)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Ping An Biomedical Co Ltd (NASDAQ-PASW) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Ping An Biomedical Co Ltd (NASDAQ-PASW) Stock FAQ

Quick answers about Ping An Biomedical Co Ltd (NASDAQ-PASW) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.13
Estimated downside 15.3%
Valuation Rating
Overvalued
Estimated downside of 15.3%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Ping An Biomedical Co Ltd (NASDAQ-PASW) is $0.13. This implies an estimated downside of 15.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 15.3% versus the current market price.

An analyst price target for Ping An Biomedical Co Ltd (NASDAQ-PASW) is not currently available in the latest data file.

The current financial health read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Ping An Biomedical Co Ltd (NASDAQ-PASW) is -9.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ping An Biomedical Co Ltd is 18.172 M.

The current enterprise value listed for Ping An Biomedical Co Ltd is 19.008 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ping An Biomedical Co Ltd is NASDAQ-PASW, and the stock is listed on NASDAQ.

Ping An Biomedical Co Ltd (NASDAQ-PASW) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Ping An Biomedical Co Ltd is 7.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ping An Biomedical Co Ltd is 78.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Distributors Stocks on NASDAQ View more

Pool Corporation (POOL) Pool Corporation (POOL)
LKQ Corporation (LKQ) LKQ Corporation (LKQ)
Polibeli Group Ltd (PLBL) Polibeli Group Ltd (PLBL)
GigaCloud Technology Inc (GCT) GigaCloud Technology Inc (GCT)
Weyco Group Inc (WEYS) Weyco Group Inc (WEYS)
Agencia Comercial Spirits Ltd (AGCC) Agencia Comercial Spirits Ltd (AGCC)
Alliance Entertainment Holding Corp (AENT) Alliance Entertainment Holding Corp (AENT)
AsiaStrategy (SORA) AsiaStrategy (SORA)
JLong Group Ltd (JL) JLong Group Ltd (JL)
Epsium Enterprise Ltd (EPSM) Epsium Enterprise Ltd (EPSM)
Redcloud Holdings Ltd (RCT) Redcloud Holdings Ltd (RCT)
Educational Development Corporation (EDUC) Educational Development Corporation (EDUC)
INNEOVA Holdings Ltd (INEO) INNEOVA Holdings Ltd (INEO)
Raytech Holding Ltd (RAY) Raytech Holding Ltd (RAY)
707 Cayman Holdings Ltd (JEM) 707 Cayman Holdings Ltd (JEM)
Greenlane Holdings Inc (GNLN) Greenlane Holdings Inc (GNLN)